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Clinics and pathology 
Disease 
Acute myeloid leukemia (AML-M7) 
Epidemiology 
This is a rare chromosomal rearrangement, only 
reported twice, without molecular characterization 
(Sessarego et al., 1989; Shimizu et al., 1991). 
Clinics 
A 5-year old girl seen for paleness, hypertrophic 
amygdala, bilateral cervical adenopathies, 
splenomegaly, and anemia. 
Cytology 
Blast morphology was indicative of acute 
megakaryoblastic leukemia; immunophenotype: CD7+, 
CD33+, CD34+. 
Pathology 
Bone marrow was hypercellular, with 100% blasts. 
Treatment 
The patient received standard induction chemotherapy 
leading to complete remission followed by 
consolidation, then maintenance therapy. 
Evolution 




The t(5;12)(p13;p13) involves the ETV6 gene (12p13), 
a transcription factor frequently rearranged in myeloid 
and lymphoid leukemias.  
More than 30 ETV6 fusion gene partners have been 
described.  
Most translocations involving ETV6 generate fusion 
genes that lead to the activation of transcription factors 
or kinases but other mechanisms are also known (loss 
of function of the fusion gene, affecting ETV6 and the 
partner gene, activation of a proto-oncogene in the 
vicinity of a chromosomal translocation and dominant 
negative effect of the fusion protein over transcriptional 
repression mediated by wild-type ETV6) (De 
Braekeleer et al., 2012). 
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t(5;12)(p13;p13) as the sole abnormality at diagnosis 
and relapse. 
Cytogenetics molecular 
FISH showed that the breakpoint on 12p13 was located 
in ETV6. To confirm the position of the breakpoint on 
chromosome 5, BACs located at 5p13 were used as 
probes in FISH experiments. Analysis on BM cells of 
the patient with RP11-140A7 showed that one signal 
hybridized to the normal chromosome 5, and the other 
split and hybridized to both der(5) and der(12).  
Co-hybridization with the RP11-140A7 clone and an 
ETV6 probe showed two yellow fusion signals. RP11-
140A7 contains the NIPBL gene. 





The ETV6 gene encodes a transcription factor 
frequently rearranged in myeloid and lymphoid 





Mutations in NIPBL (Nipped-B homolog (Drosophila), 
alias Scc2 "sister chromatid cohesion 2 homolog 
(yeast)") result in Cornelia de Lange syndrome, a 
disorder characterized by dysmorphic facial features, 
growth delay, limb reduction defects, and mental 
retardation (Krantz et al., 2004; Tonkin et al., 2004). 
DNA/RNA 
The NIPBL gene contains 47 exons spanning 188 kb, 
with the coding sequence starting in exon 2. Two 
different isoforms are generated by two transcript 
variants. A first transcript, starting in exon 2, continues 
to exon 47 and the second transcript continues to an 
expanded variant of exon 46. 
Protein 
The first transcript leads to a 2804 amino acids isoform 
and the second transcript to a 2697 amino acids 
isoform. Both isoforms are identical from amino acid 1 
to 2683 while the C-terminal ends are unrelated. The 
NIPBL protein is a complex molecule containing, 
among others, a nuclear localization signal, a nuclear 
export signal, 5 HEAT repeats and a DNA-binding 
domain. The NIPBL protein is a subunit of the cohesin 
loading complex  
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that mediates cohesion of sister chromatids (Ciosk et 
al., 2000). NIPBL also represses promoter activity via 
the recruitment of histone deacetylases (Jahnke et al., 
2008). 
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